SCHEMBL1801672

SCHEMBL1801672

CC(C)CC(C(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.56
HSD17B10 Q99714 1/20 0.56
TDP1 Q9NUW8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
MITF O75030 2/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
GFER P55789 1/20 0.51
PAX8 Q06710 1/20 0.51
ATM Q13315 1/20 0.51
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
CYP1A1 P04798 1/20 0.48
CYP19A1 P11511 1/20 0.48
PGR P06401 1/20 0.47
ADRA2A P08913 1/20 0.47
ADRA2B P18089 1/20 0.47
HTR2A P28223 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7580361 0.88 L3MBTL1 (0.59) LMNAHSD17B10TDP1L3MBTL1ALDH1A1
SCHEMBL19659491 0.86 LMNA (0.50) LMNAHSD17B10TDP1L3MBTL1ALDH1A1
SCHEMBL633843 0.85 MEN1 (0.51) LMNAALDH1A1SMN1; SMN2ATMHRH1
SCHEMBL633842 0.85 MEN1 (0.58) LMNAHSD17B10ALDH1A1ATMHRH1
SCHEMBL8094352 0.82 PGR (0.52) LMNAHSD17B10TDP1L3MBTL1ALDH1A1
SCHEMBL1716112 0.82 CYP2C19 (0.53) LMNAALDH1A1SMN1; SMN2CTSSCTSK
SCHEMBL29832525 0.81 L3MBTL1 (0.52) LMNAHSD17B10TDP1L3MBTL1ALDH1A1
SCHEMBL2120942 0.81 CTSS (0.49) LMNAHSD17B10ALDH1A1CTSSCTSK
SCHEMBL10345706 0.81 LMNA (0.53) LMNAHSD17B10TDP1L3MBTL1ALDH1A1
SCHEMBL50454 0.81 LMNA (0.80) LMNAHSD17B10TDP1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760899-B1 COATING COMPOSITION AND USE THEREOF PPG EUROPE B V (NL) 2020-08-19 EP disclosed
US-20170196990-A1 METHOD OF SYNTHESISING ADCS USING PHOTOCLEAVABLE LINKERS ON SOLID SUPPORT ADC BIOTECHNOLOGY LTD. (GB) 2017-07-13 US disclosed
EP-1778751-B1 CARBOHYDRATE BASED ALKYDS SHERWIN-WILLIAMS LUXEMBOURG INVEST MAN COMPANY S À R L (LU) 2017-03-01 EP disclosed
US-9145501-B2 Coating composition and use thereof PPG EUROPE BV (NL) 2015-09-29 US disclosed
US-20140221520-A1 Coating Composition and Use Thereof PPG EUROPE BV (NL) 2014-08-07 US disclosed
EP-2760899-A1 COATING COMPOSITION AND USE THEREOF PPG Europe B.V. (NL) 2014-08-06 EP disclosed
WO-2013045475-A1 COATING COMPOSITION AND USE THEREOF PPG EUROPE BV (NL) 2013-04-04 WO disclosed
US-7951429-B2 High energy curable coatings comprising thermoplastic polymers THE SHERWIN-WILLIAMS COMPANY (US) 2011-05-31 US disclosed
US-20090214877-A1 HIGH ENERGY CURABLE COATINGS COMPRISING THERMOPLASTIC POLYMERS THE SHERWIN-WILLIAMS COMPANY (US) 2009-08-27 US disclosed
US-7527864-B2 High energy curable coatings comprising thermoplastic polymers THE SHERWIN-WILLIAMS COMPANY (US) 2009-05-05 US disclosed
US-20060036029-A1 Carbohydrate based alkyds SHERWIN-WILLIAMS COMPANY, THE 2006-02-16 US disclosed
US-20050209358-A1 High energy curable coatings comprising thermoplastic polymers SHERWIN-WILLIAMS COMPANY THE 2005-09-22 US disclosed
WO-2005087875-A1 HIGH ENERGY CURABLE COATINGS COMPRISING THERMOPLASTIC POLYMERS THE SHERWIN-WILLIAMS COMPANY (US) 2005-09-22 WO disclosed
US-6787225-B2 MIXTURE CONTAINING PHOTOINTIATOR AND WAX THE SHERWIN-WILLIAMS COMPANY 2004-09-07 US disclosed
US-20030054116-A1 Radiation curable coating having low gloss and coated articles made therefrom THE SHERWIN-WILLIAMS COMPANY 2003-03-20 US disclosed
US-6448302-B1 DI- AND/OR TRIACRYLATED MONOMERS, INITIATOR, WAX AND UNSATURATED SILANE SURFACE TREATED PIGMENT; EXPOSURE TO RADIATION IN PRESENCE OF OXYGEN; LOW GLOSS, SMOOTH, ABRASION RESISTANT SHEET WHICH CAN ERASIBLY MARKED THE SHERWIN-WILLIAMS COMPANY 2002-09-10 US disclosed
WO-2001053421-A1 RADIATION CURABLE COATINGS HAVING LOW GLOSS AND COATED ARTICLES MADE THEREFROM THE SHERWIN-WILLIAMS COMPANY (US) 2001-07-26 WO disclosed
US-5559163-A PHOTOINITIATOR, UNSATURATED PHOTOPOLYMERIZABLE UV ABSORBER, ACRYLIC MONOMER, SILICA THE SHERWIN-WILLIAMS COMPANY (US) 1996-09-24 US disclosed
US-4601797-A Electrochemical carboxylation of p-isobutylacetophenone and other aryl ketones MONSANTO COMPANY (US) 1986-07-22 US disclosed
US-4582577-A Electrochemical carboxylation of p-isobutylacetophenone MONSANTO COMPANY (US) 1986-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170196990-A1 METHOD OF SYNTHESISING ADCS USING PHOTOCLEAVABLE LINKERS ON SOLID SUPPORT SBDS, ADCY8, DCK LMNA 2775/4885HSD17B10 3595/4885TDP1 2529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.